Loading...
•
Sep 30, 2022
Omega Healthcare Q3 2022 Earnings Report
Omega Healthcare's performance was impacted by operator restructurings and asset sales, but also benefited from new investments and Medicaid reimbursement rate increases.
Key Takeaways
Omega Healthcare Investors reported a net income of $105.1 million for the quarter ended September 30, 2022, a decrease of $37.8 million compared to the same period in 2021. Revenues totaled $239.4 million, a decrease of $42.2 million over the same period in 2021. The decrease primarily resulted from asset sales, operator restructurings, and no rental income from Agemo Holdings, LLC.
Net income for the quarter was $105 million, or $0.43 per common share.
Nareit Funds From Operations (FFO) for the quarter was $159 million, or $0.65 per common share.
Adjusted Funds From Operations (AFFO) for the quarter was $185 million, or $0.76 per common share.
Completed $28 million in real estate acquisitions and invested $40 million in a new loan.
Omega Healthcare
Omega Healthcare
Omega Healthcare Revenue by Segment
Revenue by Segment
Miscellaneous Income Revenue
CapyFin.com Forward Guidance
Omega Healthcare anticipates that resuming lease payments from restructured operators and repurposed proceeds from asset sales will enhance dividend coverage and leverage metrics by early next year.
Positive Outlook
- Expects combination of resuming lease payments from restructured operators.
- Expects repurposed proceeds from asset sales to be reflected in adjusted FFO and FAD.
- Anticipates further enhancement of dividend coverage.
- Anticipates further enhancement of leverage metrics.
- Believes skilled nursing industry is well positioned to benefit from multi-decade demographic tailwinds.
Challenges Ahead
- Occupancy continues to slowly improve.
- Many states have implemented strong Medicaid reimbursement rate increases.
- Occupancy still not having fully returned.
- Operators struggling with a higher cost environment.
- Near-term risk of further operator issues remains elevated.